Clinical Trial Update: A Study to Evaluate the Safety of the Respiratory Syncytial Virus Vaccine MEDI7510 in Older Adults [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety of the RSV vaccine MEDI7510 in older adults has completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• MEDI7510

Snippet

Sponsor: MedImmune LLC | Conditions: Respiratory Syncytial Virus (RSV) | Phase 1 | Status: COMPLETED | Results posted: 2016-10-21